AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22130826 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Escherichia coli Nissle 1917 (EcN), n=60, given for 12 weeks
Number of subjects: 120
Study 22130826 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n=60, given for 12 weeks
Number of subjects: 120
Study 20101174 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy (within 48 hours of admission)
Number of subjects: 50
Study 20101174 — intervention group
Group type: COMPARATOR
Intervention: Control laparoscopic cholecystectomy (after resolution of abdominal pain and normalizing trend of laboratory enzymes)
Number of subjects: 50
Study 20101174 — intervention group
Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy
Number of subjects: 50
Study 20101174 — intervention group
Group type: COMPARATOR
Intervention: Control laparoscopic cholecystectomy
Number of subjects: 50
Study 18052559 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine (100-200 mg/day)
Number of subjects: 234
Study 18052559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 16086912 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy supplemental beam radiation
Number of subjects: 165
Study 16086912 — intervention group
Group type: COMPARATOR
Intervention: 44 Gy supplemental beam radiation
Number of subjects: 165
Study 16086912 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy supplemental beam radiation (PSA <10 ng/ml)
Number of subjects: 165
Study 16086912 — intervention group
Group type: COMPARATOR
Intervention: 44 Gy supplemental beam radiation (PSA <10 ng/ml)
Number of subjects: 165
Study 16086912 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Gy supplemental beam radiation (PSA >10 ng/ml)
Number of subjects: 165
Study 16086912 — intervention group
Group type: COMPARATOR
Intervention: 44 Gy supplemental beam radiation (PSA >10 ng/ml)
Number of subjects: 165
Study 12150649 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate antidepressant treatment
Number of subjects: 165
Study 12150649 — intervention group
Group type: EXPERIMENTAL
Intervention: Less severe depression
Number of subjects: 165
Study 12150649 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 165
Study 12150649 — intervention group
Group type: EXPERIMENTAL
Intervention: Being married
Number of subjects: 165
Study 12150649 — intervention group
Group type: EXPERIMENTAL
Intervention: High personality dysfunction scores
Number of subjects: 165
Study 12150649 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate pharmacotherapy
Number of subjects: 165
Study 9873968 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 75 micrograms
Number of subjects: 80
Study 9873968 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 150 micrograms
Number of subjects: 80
Study 9873968 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 80
Study 9873968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 8552433 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal dexamethasone (DEX)
Number of subjects: 76
Study 8552433 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 76
Study 2371016 — intervention group
Group type: EXPERIMENTAL
Intervention: Solco‐trans device
Number of subjects: 12
Study 2371016 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemonetics cell saver
Number of subjects: 12
Study 2371016 — intervention group
Group type: COMPARATOR
Intervention: Normal volunteers
Number of subjects: 12
Study 282073 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide diuretics
Number of subjects: 206
Study 282073 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy for hypertension
Number of subjects: 206
Study 30857423 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation by a novice sonographer orthopedic surgeon
Number of subjects: 10
Study 30857423 — intervention group
Group type: COMPARATOR
Intervention: Open exposure of the transverse carpal ligament (used as a reference standard)
Number of subjects: 10
Study 28212252 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured predischarge discussion (DG)
Number of subjects: 190
Study 28212252 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 190
Study 25569647 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (Group F)
Number of subjects: 80
Study 25569647 — intervention group
Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 80
Study 23052625 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet only (DI)
Number of subjects: 48
Study 23052625 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise (DI + EXE)
Number of subjects: 48
Study 20816033 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 20816033 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study 20816033 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 0
Study 20816033 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 0
Study 20816033 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 0
Study 18282726 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurology consultation
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: Referral letter
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: History taking in clinic
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: Physical examination
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: Investigations
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: Neuro-imaging
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: EEG
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: Cardiac testing
Number of subjects: 158
Study 18282726 — intervention group
Group type: COMPARATOR
Intervention: Blood tests
Number of subjects: 158
Study 17239279 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal therapy with bicalutamide
Number of subjects: 0
Study 17239279 — intervention group
Group type: COMPARATOR
Intervention: Escalated-dose external-beam radiation therapy
Number of subjects: 0
Study 12481147 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (300 mg/kg)
Number of subjects: 0
Study 12481147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11217015 — intervention group
Group type: EXPERIMENTAL
Intervention: 0 kg external load
Number of subjects: 42
Study 11217015 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 kg external load
Number of subjects: 42
Study 11217015 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 kg external load
Number of subjects: 42
Study 9140680 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 5 mg orally once per day (max 20 mg once per day)
Number of subjects: 100
Study 9140680 — intervention group
Group type: COMPARATOR
Intervention: Captopril 12.5 mg orally once per day (max 25 mg twice per day)
Number of subjects: 100
Study 9140680 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 5-20 mg once daily
Number of subjects: 100
Study 9140680 — intervention group
Group type: COMPARATOR
Intervention: Captopril 12.5-50 mg daily
Number of subjects: 100
Study 8197755 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg S(+) ibuprofen daily (3 x 200mg) for 14 days
Number of subjects: 41
Study 8197755 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg S(+) ibuprofen daily (3 x 300mg) for 14 days
Number of subjects: 41
Study 3585223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (1.0 microgram/kg per min) with angiotensin II infusion
Number of subjects: 6
Study 3585223 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion (graded doses: 0.5, 1 and 5 micrograms/kg per min) with angiotensin II (6 ng/kg per min)
Number of subjects: 6
Study 3585223 — intervention group
Group type: COMPARATOR
Intervention: Placebo with angiotensin II infusion
Number of subjects: 6
Study 1646068 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose dactinomycin (60 micrograms/kg x 1 day)
Number of subjects: 176
Study 1646068 — intervention group
Group type: COMPARATOR
Intervention: Fractionated-dose dactinomycin (15 micrograms/kg/d x 5 days)
Number of subjects: 176
Study 1274885 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily protein intake of 29 g
Number of subjects: 12
Study 1274885 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily protein intake of 54 g
Number of subjects: 12
Study 1274885 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily protein intake of 84 g
Number of subjects: 12
Study 31558274 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-implant group (n=22)
Number of subjects: 24
Study 31558274 — intervention group
Group type: COMPARATOR
Intervention: Single-implant group (n=11)
Number of subjects: 24
Study 31558274 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-implant participants
Number of subjects: 24
Study 31558274 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-implant participants
Number of subjects: 24
Study 30858346 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual users of cigarettes and e-cigarettes
Number of subjects: 0
Study 30858346 — intervention group
Group type: COMPARATOR
Intervention: Cigarette users
Number of subjects: 0
Study 30858346 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual users
Number of subjects: 0
Study 28912947 — intervention group
Group type: EXPERIMENTAL
Intervention: Friction massage
Number of subjects: 58
Study 28912947 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Number of subjects: 58
Study 25888114 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Yunshou exercise
Number of subjects: 250
Study 25888114 — intervention group
Group type: COMPARATOR
Intervention: Balance rehabilitation training
Number of subjects: 250
Study 23808108 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle counseling (modified Mediterranean diet and moderate physical exercise for 30 min/day)
Number of subjects: 53
Study 21130598 — intervention group
Group type: EXPERIMENTAL
Intervention: Short, metaphyseal‐fitting femoral component
Number of subjects: 50
Study 21130598 — intervention group
Group type: COMPARATOR
Intervention: Conventional metaphyseal‐ and diaphyseal‐filling femoral component
Number of subjects: 50
Study 21130598 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 19643002 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention group
Number of subjects: 57
Study 19643002 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study 17197963 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow resection margin (1 cm)
Number of subjects: 169
Study 17197963 — intervention group
Group type: COMPARATOR
Intervention: Wide resection margin (2 cm)
Number of subjects: 169
Study 12835983 — intervention group
Group type: COMPARATOR
Intervention: CO(2) with placebo
Number of subjects: 181
Study 12835983 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebeverine
Number of subjects: 181
Study 10783998 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 133
Study 10783998 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sulphasalazine 5-ASA drug
Number of subjects: 133
Study 10783998 — intervention group
Group type: COMPARATOR
Intervention: Irritable bowel syndrome (control)
Number of subjects: 133
Study 10783998 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulcerative colitis
Number of subjects: 133
Study 10783998 — intervention group
Group type: EXPERIMENTAL
Intervention: Crohn's disease
Number of subjects: 133
Study 8875814 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 5‐mg, 10‐mg, 15‐mg, 20‐mg
Number of subjects: 2
Study 8875814 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional Training (AT)
Number of subjects: 2
Study 8875814 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 2
Study 1425620 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study 6337306 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg daily postoperatively
Number of subjects: 116
Study 6337306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 31045768 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanao decoction (SAD)
Number of subjects: 0
Study 27649641 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin‐releasing hormone agonist (GnRHa) goserelin
Number of subjects: 58
Study 25960403 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid cycle
Number of subjects: 19
Study 25960403 — intervention group
Group type: EXPERIMENTAL
Intervention: Handcycle
Number of subjects: 19
Study 25960403 — intervention group
Group type: COMPARATOR
Intervention: Hybrid cycle and Handcycle
Number of subjects: 19
Study 24091175 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic doses of low molecular weight heparin
Number of subjects: 50
Study 21779829 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoid resection (LSR)
Number of subjects: 143
Study 21779829 — intervention group
Group type: COMPARATOR
Intervention: Open sigmoid resection (OSR)
Number of subjects: 143
Study 19786444 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral weight control intervention
Number of subjects: 192
Study 19786444 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 192
Study 19786444 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral weight control intervention (for children attending > or =75% of sessions)
Number of subjects: 192
Study 16394886 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous bolus injection of deferoxamine (DFO)
Number of subjects: 20
Study 16394886 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous continuous infusion of deferoxamine (DFO)
Number of subjects: 20
Study 16394886 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Subcutaneous bolus injection and Subcutaneous continuous infusion)
Number of subjects: 20
Study 15349783 — intervention group
Group type: EXPERIMENTAL
Intervention: SCI
Number of subjects: 12
Study 15349783 — intervention group
Group type: COMPARATOR
Intervention: AB
Number of subjects: 12
Study 11117271 — intervention group
Group type: EXPERIMENTAL
Intervention: Local allergoid immunotherapy for 3 months before the pollen season
Number of subjects: 24
Study 11117271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9338948 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra self‐administered fitness training
Number of subjects: 0
Study 9338948 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 7505143 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated group
Number of subjects: 153
Study 7505143 — intervention group
Group type: COMPARATOR
Intervention: Non-vaccinated group
Number of subjects: 153
Study 7505143 — intervention group
Group type: COMPARATOR
Intervention: AntiHBs and antiHBc positive infants
Number of subjects: 153
Study 3887393 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment with anti-thymocyte globulin (ATG)
Number of subjects: 88
Study 3887393 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (Cys) alone
Number of subjects: 88
Study 3887393 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential combination of ATG with Cys
Number of subjects: 88
Study 31491931 — intervention group
Group type: EXPERIMENTAL
Intervention: Forest resting environments (7 types)
Number of subjects: 96
Study 31491931 — intervention group
Group type: EXPERIMENTAL
Intervention: Water landscape environment
Number of subjects: 96
Study 31491931 — intervention group
Group type: EXPERIMENTAL
Intervention: Most natural environment
Number of subjects: 96
Study 30821824 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg preoperatively, 600 mg 3 times a day postoperatively for 72 hours)
Number of subjects: 422
Study 30821824 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (lorazepam 0.5 mg preoperatively, inactive placebo postoperatively for 72 hours)
Number of subjects: 422
Study 30821824 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst pain reported on postoperative day 10
Number of subjects: 422
Study 28159043 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics (Group 1)
Number of subjects: 100
Study 28159043 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics (Group 2)
Number of subjects: 100
Study 26643736 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided group (n=114)
Number of subjects: 229
Study 26643736 — intervention group
Group type: COMPARATOR
Intervention: Routine-DES group (n=115)
Number of subjects: 229
Study 21864917 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose bolus tirofiban
Number of subjects: 745
Study 21864917 — intervention group
Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 745
Study 21864917 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 745
Study 21864917 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 745
Study 21975093 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic block of the anterior and posterior interosseous nerves
Number of subjects: 80
Study 21975093 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 80
Study 18315419 — intervention group
Group type: EXPERIMENTAL
Intervention: DBM
Number of subjects: 55
Study 18315419 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR
Number of subjects: 55
Study 18315419 — intervention group
Group type: EXPERIMENTAL
Intervention: Other BRGs
Number of subjects: 55
Study 18315419 — intervention group
Group type: COMPARATOR
Intervention: OFD
Number of subjects: 55
Study 17059294 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-week worksite exercise/behavioral intervention
Number of subjects: 73
Study 17059294 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study 12635534 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin alone (500 mg i.v. for 1-2 days, then 250 mg orally for 7 days)
Number of subjects: 309
Study 12635534 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin with metronidazole (500 mg i.v. for 1-2 days, then 250 mg orally for 7 days + 400 mg or 500 mg metronidazole i.v. then orally for 12-14 days)
Number of subjects: 309
Study 12635534 — intervention group
Group type: COMPARATOR
Intervention: Comparator regimens (metronidazole + doxycycline + cefoxitin + probenecid or doxycycline + amoxycillin/clavulanate for up to 21 days)
Number of subjects: 309
Study 12635534 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (including azithromycin alone, azithromycin with metronidazole, and comparator regimens)
Number of subjects: 309
Study 10874261 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalaprilat infusion (3-hour duration)
Number of subjects: 7
Study 10874261 — intervention group
Group type: COMPARATOR
Intervention: Control group (historic)
Number of subjects: 7
Study 9412796 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection (TUR)
Number of subjects: 186
Study 9412796 — intervention group
Group type: COMPARATOR
Intervention: Age-matched control group
Number of subjects: 186
Study 8517425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg) administered once daily at bedtime
Number of subjects: 408
Study 8517425 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered once daily at bedtime
Number of subjects: 408
Study 2896557 — intervention group
Group type: EXPERIMENTAL
Intervention: High bio-availability glaphenine
Number of subjects: 78
Study 2896557 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 78
Study 30405295 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 940
Study 30405295 — intervention group
Group type: COMPARATOR
Intervention: Standard ED evaluation
Number of subjects: 940
Study 28458078 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing designed to elicit change talk
Number of subjects: 100
Study 28458078 — intervention group
Group type: COMPARATOR
Intervention: Placebo counseling designed not to elicit change talk
Number of subjects: 100
Study 28458078 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment
Number of subjects: 100
Study 24975233 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentence training
Number of subjects: 40
Study 24975233 — intervention group
Group type: COMPARATOR
Intervention: Passive exposure
Number of subjects: 40
Study 24975233 — intervention group
Group type: EXPERIMENTAL
Intervention: Consonant training
Number of subjects: 40
Study 24975233 — intervention group
Group type: COMPARATOR
Intervention: Test-only
Number of subjects: 40
Study 23653431 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D- and calcium-fortified yogurt (FY) providing 10 μg/d vitamin D₃ and 800 mg/d calcium
Number of subjects: 56
Study 23653431 — intervention group
Group type: COMPARATOR
Intervention: Nonfortified control yogurt (CY) providing 280 mg/d calcium
Number of subjects: 56
Study 23653431 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D- and calcium-fortified yogurt (FY)
Number of subjects: 56
Study 23653431 — intervention group
Group type: COMPARATOR
Intervention: Nonfortified control yogurt (CY)
Number of subjects: 56
Study 20559103 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine combined with SCS
Number of subjects: 10
Study 20559103 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen combined with SCS
Number of subjects: 10
Study 20559103 — intervention group
Group type: COMPARATOR
Intervention: SCS alone
Number of subjects: 10
Study 19098696 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 0
Study 19098696 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 0
Study 16311044 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating floor at frequencies of 0.1, 0.5, 1.0, and 1.5 Hz
Number of subjects: 23
Study 16311044 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior-dominant muscles in the trunk and thigh
Number of subjects: 23